Cardiac Autonomic Neuropathy (CAN) is a serious and often under-recognized complication of diabetes and other systemic conditions, characterized by impaired autonomic control of heart rate and vascular tone. This session examines the pathophysiology, clinical manifestations, and prognostic implications of CAN, with a strong focus on early detection and risk reduction. Participants will learn how autonomic damage contributes to resting tachycardia, orthostatic hypotension, exercise intolerance, silent ischemia, and increased mortality. The session underscores the importance of routine screening in at-risk populations.

Healthcare professionals increasingly look for a cardiology conference to better understand how to diagnose and manage this complex condition. This session reviews diagnostic tools such as heart rate variability analysis, blood pressure response testing, and standardized autonomic reflex testing. Attendees will gain insight into which patients to screen, how to interpret test results, and how to integrate findings with overall cardiovascular risk assessment. Case-based discussions will highlight typical presentations, including syncope, dizziness, and silent myocardial ischemia in patients with long-standing diabetes.

A key theme is understanding diabetic autonomic neuropathy as part of comprehensive cardiometabolic care. Participants will explore the interplay between glycemic control, blood pressure management, lipid therapy, and lifestyle interventions in preventing or slowing CAN progression. The session emphasizes multidisciplinary collaboration between cardiology, endocrinology, neurology, and primary care. Practical strategies for managing orthostatic symptoms, optimizing medication regimens, and advising on safe physical activity are discussed in detail, always framed within a holistic cardiovascular prevention plan.

The session also addresses patient education and long-term follow-up, recognizing that CAN significantly affects quality of life and safety. Attendees will learn how to counsel patients about symptom recognition, hydration, positional strategies, and the importance of regular monitoring. By the end, clinicians will have a structured approach to screening, diagnosing, and managing cardiac autonomic neuropathy, ensuring it is no longer overlooked in high-risk populations.